A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social
LONDON (AP) — Queen Elizabeth II has used her birthday honors list to celebrate those at the forefront of the U.K. s rapid rollout of COVID-19 vaccines over the past few
The Food and Drug Administration’s decision next week whether to approve the first treatment for Alzheimer’s disease highlights a deep division over the drug’s benefits as well as criticism about
CAMBRIDGE, Mass. (BUSINESS WIRE) Jun 2, 2021
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has entered into an additional agreement with Lonza (SIX: LONN) to support drug substance manufacturing for its global supply chain. The agreement will establish a new production line at Lonzaâs Geleen site in the Netherlands, contributing to the supply of an additional 300 million doses of Modernaâs updated booster variant vaccine candidate, if authorized, per year, at a 50 µg dose.
In addition to previously announced investments in drug substance manufacturing with ROVI in Granada, Spain, the Company now expects to be able to supply the equivalent of 600 million 50 µg doses per year from production within the European Union. Both new drug substance lines in the European Union are expected to be operational before the end of 2021.
DNA Explainer: How to administer 2-DG drug on COVID-19 patients, DRDO guidelines - The oral drug cleared by the Drugs Controller General of India on May 1 for emergency use, is an adjunct therapy to treat severe COVID-19 patients.